Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia

Biological Psychiatry

Volumn 46, Issue 5, 1999, Pages 616-626

  Lewis, David A ^a,b   Pierri, Joseph N ^a   Volk, David W ^b   Melchitzky, Darlene S ^b   Woo, Tsung Ung W ^a  

^a Department Ofpsychiatry ^*  (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Chandelier neuron; GABA membrane transporter; Glutamic acid decarboxylase; Parvalbumin; Pyramidal cell

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; PARVALBUMIN;

CONFERENCE PAPER; HUMAN; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA;

ADOLESCENT; ANIMALS; AXONS; CHILD; CHILD, PRESCHOOL; GAMMA-AMINOBUTYRIC ACID; HUMANS; INFANT; MEMORY; NEURONS; PREFRONTAL CORTEX; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION;

EID: 0032814333     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00061-X     Document Type: Conference Paper

References (95)

1. A receptor subunit gene expression in human prefrontal cortex comparison of schizophrenics and controls . Cereb Cortex. 5:1995;550-560.
2. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E. Jr, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52:1995;258-266.
3. Akil M., Lewis D.A. Differential distribution of parvalbumin-immunoreactive pericellular clusters of terminal boutons in developing and adult monkey neocortex. Exp Neurol. 115:1992;239-249.
4. Anderson S.A., Classey J.D., Condé F., Lund J.S., Lewis D.A. Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience. 67:1995;7-22.
5. Andreasen N.C., Arndt S., Swayze V. II, Cizaldo T., Flaum M., O'Leary D., et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science. 266:1994;294-298.
6. Andreasen N.C., Flashman L., Flaum M., Arndt S., Swayze V. II, O'Leary D.S., et al. Regional brain abnormalities in schizophrenia measured with magnetic resonance imaging. JAMA. 272:1994;1763-1769.
7. Arnsten A.F.T., Cai J.X., Murphy B.L., Goldman-Rakic P.S. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology. 116:1994;143-151.
8. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 48:1991;996-1001.
9. Benes F.M., Snyder-Marie A., Vincent S., Khan Y. Up-regulation of GABA-A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 75:1996;1021-1031.
10. Benes F.M., Todtenkopf M.S., Vincent S.L. Meta-analysis of nonpyramidal neuron loss in layer II in anterior cingulate cortex from three studies of postmortem schizophrenic brain. Soc Neurosci Abstr. 24:1998;1275.
11. Benson D.L., Huntsman M.M., Jones E.G. Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys. Cereb Cortex. 4:1994;40-51.
12. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T.W., et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry. 153:1996;1554-1563.
13. Bird E.D., Spokes E.G.S., Iversen L.L. Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia. Brain. 102:1979;347-360.
14. Borden L.A., Dhar T.G.M., Smith K.E., Weinshank R.L., Branchek T.A., Gluchowski C. Tiagabine, SK & F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol. 269:1994;219-224.
15. Bourgeois J.-P., Goldman-Rakic P.S., Rakic P. Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex. 4:1994;78-96.
16. Breier A., Buchanan R.W., Elkashef A., Munson R.C., Kirkpatrick B., Gellad F. Brain morphology and schizophrenia a magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures . Arch Gen Psychiatry. 49:1992;921-926.
17. Brozoski T.J., Brown R.M., Rosvold H.E., Goldman P.S. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkeys. Science. 205:1979;929-932.
18. Buschbaum M.S., Someya T., Teng C.Y., Abel L., Chin S., Najafi A., et al. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am J Psychiatry. 153:1996;191-199.
19. Celio M.R. Parvalbumin in most gamma-aminobutyric acid-containing neurons of the rat cerebral cortex. Science. 231:1986;995-998.
20. Colonnier M. Synaptic patterns on different cell types in the different laminae of the cat visual cortex. An electron microscope study. Brain Res. 9:1968;268-287.
21. Condé F., Lund J.S., Jacobowitz D.M., Baimbridge K.G., Lewis D.A. Local circuit neurons immunoreactive for calretinin, calbindin D-28k, or parvalbumin in monkey prefrontal cortex distribution and morphology . J Comp Neurol. 341:1994;95-116.
22. Condé F., Lund J.S., Lewis D.A. The hierarchical development of monkey visual cortical regions as revealed by the maturation of parvalbumin-immunoreactive neurons. Dev Brain Res. 96:1996;261-276.
23. Daviss S.R., Lewis D.A. Local circuit neurons of the prefrontal cortex in schizophrenia selective increase in the density of calbindin-immunoreactive neurons . Psychiatry Res. 59:1995;81-96.
24. DeFelipe J., Farinas I. The pyramidal neuron of the cerebral cortex morphological and chemical characteristics of the synaptic inputs . Prog Neurobiol. 39:1992;563-607.
25. DeFelipe J., Hendry S.H.C., Jones E.G. Visualization of chandelier cell axons by parvalbumin immunoreactivity in monkey cerebral cortex. Proc Natl Acad Sci USA. 86:1989;2093-2097.
26. Deicken R.F., Zhou L., Corwin F., Vinogradov S., Weiner M.W. Decreased left frontal lobe N-acetylaspartate in schizophrenia. Am J Psychiatry. 154:1997;688-690.
27. del Río M.R., DeFelipe J. Synaptic connections of calretinin-immunoreactive neurons in the human neocortex. J Neurosci. 17:1997;5143-5154.
28. Fairen A., DeFelipe J., Regidon J. Nonpyramidal neurons, general account. Peters A., Jones E.G. Cerebral Cortex. Vol. 1. 1984;201-245 Plenum, New York.
29. Frazier J.A., Giedd J.N., Hamburger S.D., Albus K.E., Kaysen D., Vaituzis A.C., et al. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch Gen Psychiatry. 53:1996;617-624.
30. Friedman H.R., Goldman-Rakic P.S. Coactivation of prefrontal cortex and inferior parietal cortex in working memory tasks revealed by 2DG functional mapping in the rhesus monkey. J Neurosci. 14:1994;2775-2788.
31. Fuster J.M., Bauer R.H., Jervey J.P. Functional interactions between inferotemporal and prefrontal cortex in a cognitive task. Brain Res. 330:1985;200-307.
32. Fukuzako H., Takeuchi K., Hokazono Y., Fukuzako T., Yamada K., Hashiguchi T., et al. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia preliminary report . Psychiat Res: Neuroimaging. 61:1995;193-200.
33. Gabbott P.L.A., Bacon S.J. Local circuit neurons in the medial prefrontal cortex (areas 24a,b,c, 25 and 32) in the monkey II. Quantitative areal and laminar distributions . J Comp Neurol. 364:1996;609-636.
34. Gabriel S.M., Haroutunian V., Powchik P., Honer W.G., Davidson M., Davies P., et al. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Arch Gen Psychiatry. 54:1997;559-566.
35. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 65:1998;446-453.
36. George T.P., Spence M.W. Alterations of membrane phospholipid metabolism in patients with schizophrenia assessed by phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry. 53:1996;1065-1066.
37. Giguere M., Goldman-Rakic P.S. Mediodorsal nucleus areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys . J Comp Neurol. 277:1988;195-213.
38. Gilbert C.D., Kelly J.P. The projections of cells in different layers of the cat's visual cortex. J Comp Neurol. 63:1975;81-106.
39. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
40. Glantz L.A., Lewis D.A. Specificity of decreased spine density on layer III pyramidal cells in schizophrenia. Soc Neurosci Abstr. 22:1996;1679.
41. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia regional and diagnostic specificity . Arch Gen Psychiatry. 54:1997;943-952.
42. Goldman-Rakic P.S. Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA. 93:1996;13473-13480.
43. Goldman-Rakic P.S., Leranth C., Williams S.M., Mons N., Geffard M. Dopamine synaptic complex with pyramidal neurons in primate cerebral cortex. Proc Natl Acad Sci USA. 86:1989;9015-9019.
44. Gonzalez-Burgos G., Henze D.A., Lewis D.A., Barrionuevo G. Clustered horizontal synaptic connections in macaque monkey dorsolateral prefrontal cortex brain slices. Soc Neurosci Abstr. 23:1997;1303.
45. Heizmann C.W. Parvalbumin an intracellular calcium-binding protein. Distribution properties and possible roles in mammalian cells. Experientia. 40:1984;910-921.
46. Hendry S.H.C., Jones E.G. Activity-dependent regulation of GABA expression in the visual cortex of adult monkeys. Neuron. 1:1988;701-712.
47. Hinsberger A.D., Williamson P.C., Carr T.J., Stanley J.A., Drost D.J., Densmore M., et al. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia. J Psychiatry Neuroscience. 22:1997;111-117.
48. Huntsman M.M., Tran B.V., Potkin S.G., Bunney W.E., Jones E.G. Altered ratios of alternatively spliced long and short gamma 2 subunit mRNAs of the gamma-amino butyrate type A receptor in prefrontal cortex of schizophrenics. Proc Natl Acad Sci USA. 95:1998;15066-15071.
49. Isaacson J.S., Solis J.M., Nicoll R.A. Local and diffuse synaptic action of GABA in the hippocampus. Neuron. 10:1993;165-175.
50. Karson C.N., Mrak R.E., Schluterman K.O., Sturner W.Q., Sheng J.G., Griffin W.S.T. Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophenia a possible neurochemical basis for "hypofrontality." Mol Psychiatry. 4:1999;39-45.
51. Kawaguchi Y. Physiological subgroups of nonpyramidal cells with specific morphological characteristics in layer II/III of rat frontal cortex. J Neurosci. 15:1995;2638-2655.
52. Levitt J.B., Lewis D.A., Yoshioka T., Lund J.S. Topography of pyramidal neuron intrinsic connections in macaque monkey prefrontal cortex (areas 9 & 46). J Comp Neurol. 338:1993;360-376.
53. Lewis D.A. Development of the primate prefrontal cortex. Keshavan M.S., Murray R.M. Neurodevelopment and Adult Psychopathology. 1997;12-30 Cambridge University Press, Cambridge, UK.
54. Lewis D.A., Anderson S.A. The functional architecture of the prefrontal cortex and schizophrenia. Psychol Med. 25:1995;887-894.
55. Lewis D.A., Lund J.S. Heterogeneity of chandelier neurons in monkey neocortex corticotropin-releasing factor and parvalbumin immunoreactive populations . J Comp Neurol. 293:1990;599-615.
56. Lund J.S., Holbach S. Postnatal development of thalamic recipient neurons in monkey striate cortex I. A comparison of spine acquisition and dendrtic growth of layer 4C alpha and beta spiny stellate neurons . J Comp Neurol. 309:1991;115-128.
57. Lund J.S., Lewis D.A. Local circuit neurons of developing and mature macaque prefrontal cortex Golgi and immunocytochemical characteristics . J Comp Neurol. 328:1993;282-312.
58. Lund J.S., Lund R.D., Hendrickson A.E., Bunt A.H., Fuchs A.F. The origin of efferent pathways from the primary visual cortex, area 17, of the macaque monkey as shown by retrograde transport of horseradish peroxidase. J Comp Neurol. 164:1975;287-304.
59. Mager S., Naeve J., Quick M., Labarca C., Davidson N., Lester H.A. Steady states, charge movements, and rates for a cloned GABA transporter expressed in xenopus oocytes. Neuron. 10:1993;177-188.
60. Mates S.L., Lund J.S. Spine formation and maturation of type 1 synapses on spiny stellate neurons in primate visual cortex. J Comp Neurol. 221:1983;91-97.
61. Melchitzky D.S., Sesack S.R., Lewis D.A. Parvalbumin-immunoreactive axon terminals in monkey and human prefrontal cortex laminar, regional and target specificity of type I and type II synapses . J Comp Neurol. 408:1999;11-22.
62. Melchitzky D.S., Sesack S.R., Pucak M.L., Lewis D.A. Synaptic targets of pyramidal neurons providing intrinsic horizontal connections in monkey prefrontal cortex. J Comp Neurol. 390:1998;211-224.
63. Minelli A., Brecha N.C., Karschin C., DeBiasi S., Conti F. GAT-1, a high-affinity GABA plasma membrane transporter, is localized to neurons and astroglia in the cerebral cortex. J Neurosci. 15:1995;7734-7746.
64. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry. 47:1990;1023-1028.
65. Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors. Biol Psychiatry. 34:1993;768-772.
66. Park S., Holzman P.S. Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry. 49:1992;975-982.
67. Perrone-Bizzozero N.I., Sower A.C., Bird E.D., Benowitz L.I., Ivins K.J., Neve R.L. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci USA. 93:1996;14182-14187.
68. Peters A. Chandelier cells. Jones E.G., Peters A. Cerebral Cortex, Vol. 1. 1984;361-380 Plenum Press, New York.
69. Pettegrew J.W., Keshavan M.S., Panchalingam K., Strychor S., Kaplan D.B., Tretta M.G., et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. Arch Gen Psychiatry. 48:1991;563-568.
70. Pierri J.N., Chaudry A.S., Woo T.-U., Lewis D.A. Decreased GAT-1 -immunoreactive chandelier cell axon terminals in the prefrontal cortex in schizophrenia Diagnostic and laminar specificity . Schizophr Res. 36:1998;83.
71. Pucak M.L., Levitt J.B., Lund J.S., Lewis D.A. Patterns of intrinsic and associational circuitry in monkey prefrontal cortex. J Comp Neurol. 376:1996;614-630.
72. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex a postmortem morphometric study of schizophrenia and Huntington disease . Arch Gen Psychiatry. 55:1998;215-224.
73. Reynolds G.P., Czudek C., Andrews H.B. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol Psychiatry. 27:1990;1038-1044.
74. Roberts A.C., DeSalvia M.A., Wilkinson L.S., Collins P., Muir J.L., Everitt B.J., et al. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test possible interactions with subcortical dopamine . J Neurosci. 14:1994;2531-2544.
75. Sawaguchi T., Goldman-Rakic P.S. D1 dopamine receptors in prefrontal cortex involvement in working memory . Science. 251:1991;947-950.
76. Schlaepfer T.E., Harris G.J., Tien A.Y., Peng L.W., Lee S., Federman E.B., et al. Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry. 151:1994;842-848.
77. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex a morphometric analysis of prefrontal area 9 and occipital area 17 . Arch Gen Psychiatry. 52:1995;805-818.
78. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients application of a three-dimensional, stereologic counting method . J Comp Neurol. 392:1998;402-412.
79. Sesack S.R., Bressler C.N., Lewis D.A. Ultrastructural associations between dopamine terminals and local circuit neurons in the monkey prefrontal cortex a study of calretinin-immunoreactive cells . Neurosci Lett. 200:1995;9-12.
80. Sesack S.R., Hawrylak V.A., Melchitzky D.S., Lewis D.A. Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures . Cereb Cortex. 8:1998;614-622.
81. Sesack S.R., Snyder C.L., Lewis D.A. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol. 363:1995;264-280.
82. Shelton R.C., Karson C.N., Doran A.R., Pickar D., Bigelow L.B., Weinberger D.R. Cerebral structural pathology in schizophrenia evidence for a selective prefrontal cortical defect . Am J Psychiatry. 145:1988;154-163.
83. Sherman A.D., Davidson A.T., Baruah S., Hegwood T.S., Waziri R. Evidence of glutamatergic deficiency in schizophrenia. Neurosci Lett. 121:1991;77-80.
84. Shioiri T., Kato T., Inubushi T., Murashita J., Takahashi S. Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia. Psychiat Res: Neuroimaging. 55:1994;223-235.
85. Simpson M.D.C., Slater P., Deakin J.F.W., Royston M.C., Skan W.J. Reduced GABA uptake sites in the temporal lobe in schizophrenia. Neurosci Lett. 107:1989;211-215.
86. Stanley J.A., Williamson P.C., Drost D.J., Carr T.J., Rylett R.J., Malla A., et al. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry. 52:1995;399-406.
87. Stanley J.A., Williamson P.C., Drost D.J., Rylett R.J., Carr T.J., Malla A., et al. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophr Bull. 22:1996;597-609.
88. Thune J.J., Hofsten D.E., Uylings H.B.M., Pakkenberg B. Total neuron numbers in the prefrontal cortex in schizophrenia. Soc Neurosci Abstr. 24:1998;985.
89. 67 mRNA in a subpopulation of GABA neurons in the prefrontal cortex of schizophrenic subjects. Soc Neurosci Abstr. 24:1998;986.
90. Weinberger D.R., Berman K.F., Zec R.F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry. 43:1986;114-124.
91. Wible C.G., Shenton M.E., Hokama H., Kikinis R., Jolesz F.A., Metcalf D., et al. Prefrontal cortex and schizophrenia. Arch Gen Psychiatry. 52:1995;279-288.
92. Woo T.-U., Miller J.L., Lewis D.A. Parvalbumin-containing cortical neurons in schizophrenia. Am J Psychiatry. 154:1997;1013-1015.
93. Woo T.-U., Pucak M.L., Kye C.H., Matus C.V., Lewis D.A. Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex. Neuroscience. 80:1997;1149-1158.
94. Woo T.-U., Whitehead R.E., Melchitzky D.S., Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA. 95:1998;5341-5346.
95. Zipursky R.B., Lim K.O., Sullivan E.V., Brown B.W., Pfefferbaum A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry. 49:1992;195-205.